[Pentagastrin, a histamine H2 receptor inhibitor, and human salivary secretion].
Del Vecchio-Blanco
C
C
Loguercio
C
C
Caporaso
N
N
de Sio
I
I
Romano
M
M
Focareta
R
R
Taranto
D
D
D000328:Adult; D002927:Cimetidine / Q000494:pharmacology; D005260:Female; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D010418:Pentagastrin / Q000008:administration & dosage / Q000494:pharmacology*; D011899:Ranitidine / Q000494:pharmacology; D012472:Salivation / Q000187:drug effects*; D012636:Secretory Rate / Q000187:drug effects
D006635:Histamine H2 Antagonists; D002927:Cimetidine; D011899:Ranitidine; D010418:Pentagastrin